320 related articles for article (PubMed ID: 29606612)
1. Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.
Colacino JA; Azizi E; Brooks MD; Harouaka R; Fouladdel S; McDermott SP; Lee M; Hill D; Madden J; Boerner J; Cote ML; Sartor MA; Rozek LS; Wicha MS
Stem Cell Reports; 2018 May; 10(5):1596-1609. PubMed ID: 29606612
[TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
[TBL] [Abstract][Full Text] [Related]
3. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
[TBL] [Abstract][Full Text] [Related]
4. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Vesuna F; Lisok A; Kimble B; Raman V
Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
[TBL] [Abstract][Full Text] [Related]
5. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
8. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
Hwang-Verslues WW; Kuo WH; Chang PH; Pan CC; Wang HH; Tsai ST; Jeng YM; Shew JY; Kung JT; Chen CH; Lee EY; Chang KJ; Lee WH
PLoS One; 2009 Dec; 4(12):e8377. PubMed ID: 20027313
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
11. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
[TBL] [Abstract][Full Text] [Related]
13. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
14. STAT3 as a promising chemoresistance biomarker associated with the CD44
Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
[TBL] [Abstract][Full Text] [Related]
15. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention.
Colacino JA; McDermott SP; Sartor MA; Wicha MS; Rozek LS
Breast Cancer Res Treat; 2016 Jul; 158(1):29-41. PubMed ID: 27306423
[TBL] [Abstract][Full Text] [Related]
17. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Creighton CJ; Li X; Landis M; Dixon JM; Neumeister VM; Sjolund A; Rimm DL; Wong H; Rodriguez A; Herschkowitz JI; Fan C; Zhang X; He X; Pavlick A; Gutierrez MC; Renshaw L; Larionov AA; Faratian D; Hilsenbeck SG; Perou CM; Lewis MT; Rosen JM; Chang JC
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13820-5. PubMed ID: 19666588
[TBL] [Abstract][Full Text] [Related]
18. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
[TBL] [Abstract][Full Text] [Related]
19. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
Reuben JM; Lee BN; Gao H; Cohen EN; Mego M; Giordano A; Wang X; Lodhi A; Krishnamurthy S; Hortobagyi GN; Cristofanilli M; Lucci A; Woodward WA
Eur J Cancer; 2011 Jul; 47(10):1527-36. PubMed ID: 21334874
[TBL] [Abstract][Full Text] [Related]
20. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
